Skip to content

NIVELPHARMA

Active Private limited companyfounded 2003active for 23 yearsChaussée de Mons 47, 1400 NivellesKBO/BCE: BE 0479.701.721

Lifetime

20 annual accounts with figures on one time axis, 23 filings since 2003
peak of €405,103 in 2011
€278,623▲ 1.6%
lowest -€85,865 in 2011
€65,451▲ 97.9%
peak of €124,365 in 2024
€64,316▼ 48.3%
€375,853▲ 6.6%
peak of 4.3 FTE in 2022
2.8 FTE▼ 15.2%
Board1 name since 2013
1 director
Documentsfilings and deeds
31-08-202631 days late
2025abbreviated format
Result from €33,080 to €65,451Staff from 3.3 FTE to 2.8 FTEDividend €125,500Equity from €124,365 to €64,316

Key points

from the 2025 annual accounts

Equity

€64,316 ▼ 48.3%
124,3652024+65,451Profit-125,500Dividend64,3162025

NIVELPHARMA paid out €125,500 in dividends. That is 192% of the 2025 profit.

Debts

€375,853 85% of the balance sheet
Financial debts 3%Suppliers 13%Taxes and wages 6%Other 78%

Of this, €364,853 falls due within a year.

Filings

23 annual accounts since 2003
AprilJune31 JulyOctober20102020

Four of the last ten came late. The 2025 accounts came in latest, 31 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 3,821 companies had the same profile as NIVELPHARMA has now. Each dot stands for 10 companies, two years later.

95.1%
were still trading
3.8%
stopped another way
1.0%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 3,821 companies, not a prediction for NIVELPHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 01-04-2013
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0479701721
resigns as manager reappointed as director · General meeting of 11-12-2023 · Gazette deed
resigns as manager General meeting of 06-12-2018 · Gazette deed
Registered office moved within Nivelles The registered office moved from rue de Namur 181 à 1400 Nivelles to Chaussée de Mons 47 à 1400 Nivelles · resigns as manager · appointed as manager · General meeting of 30-03-2013 · Gazette deed
All 33 events

Comparable companies

same main activity, similar in size and age
Company
NIVELPHARMA Nivelles €440,169 €278,623 14.6% 2.8
APOTHEEK TRAP Dilbeek €477,672 €281,558 40.5% 2.9
PHARMACIE DU VERT CHEMIN Nivelles €394,655 €210,990 53.8% 3
PHARMACIE LAPERCHE Evere €485,699 €330,897 42.7% 2.7
SECUNDUM ARTEM Etterbeek €496,587 €298,444 41.5% 2.4
Pharmacie BARBAY Namur €512,805 €240,609 45.8% 2.6
PHARMACIE DE LA TOUR Anderlues €490,336 €229,372 53.2% 2.6

These companies have the same main activity as NIVELPHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €395,000 and €513,000, founded between 2001 and 2004.

Official details

Source: KBO
Status
Active since 05-03-2003Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.133.181.5371400 Nivelles, since 05-03-2003
Financial year end
31 December
Peppol
Reachable since 08-05-2024
Company details

Annual accounts 2025

≈ €960,000estimated
€440,169▼ 7.7%
Employeeson 31-12-2025
4=
Filing
Filed on 31-08-2026
Financials

Insights on NIVELPHARMA

NIVELPHARMA files the abbreviated format. That format states no turnover. The gross margin rose from €10,115 in 2006 to €278,623 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NIVELPHARMA

What is the company number of NIVELPHARMA?
The company number of NIVELPHARMA is 0479.701.721. The VAT number is the same number with BE in front: BE 0479.701.721.
Where is NIVELPHARMA based?
The registered office is at Chaussée de Mons 47, 1400 Nivelles.Company details
What does NIVELPHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of NIVELPHARMA?
NIVELPHARMA is a private limited company (BV).
When was NIVELPHARMA founded?
NIVELPHARMA was founded on 05-03-2003.
Is NIVELPHARMA still active?
Yes, NIVELPHARMA is an active enterprise in the KBO register.
How many employees does NIVELPHARMA have?
NIVELPHARMA had an average of 2.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does NIVELPHARMA fall under?
In its 2025 annual accounts, NIVELPHARMA states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of NIVELPHARMA?
The turnover in financial year 2025 is about €960,000. This figure is estimated from the gross margin of €278,623 and 42 comparable companies (NACE 477). It probably lies between €760,000 and €1.3m.
Is NIVELPHARMA profitable?
In financial year 2025, NIVELPHARMA made a profit of €65,451.
Where can I find the annual accounts of NIVELPHARMA?
NIVELPHARMA filed 23 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NIVELPHARMA due?
NIVELPHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.